A centralized unit for integrated management of care pathway in Oncology has been created. This unit settles the patients' appointments (biopsy, intravenous device, chemotherapy, imaging, oncologist...). The aim of this study is to assess the delay between the first appointment with the oncologist and the beginning of the antitumoral treatment, and therefore evaluate the efficacy of the care pathway unit. The second aim is to assess the satisfaction of patients and health care teams.
PASSION is a french monocentric study. For the retrospective cohort, patient will be selected through the use of data warehouse available on the HEGP. For the prospective cohort, patient will be included according to the selection criteria. Each patient will be followed up during 6 month and a satisfaction questionnaire will be completed at 1 month and 4 month of the first administration of anti-tumor therapy. For both cohort, clinical-anatomo-biological data will be collected through the use of data warehouse available on the HEGP.
Study Type
OBSERVATIONAL
Enrollment
1,800
Patients from the prospective cohort will have their health care scheduled by the care pathway unit.
AP-HP Hôpital européen Georges-Pompidou
Paris, France
Time between the first appointment with the oncologist and the beginning of antitumoral treatment.
Delay of health care
Time frame: 6 months
Patients satisfaction
Satisfaction of patients with OUT-PATSAT35 questionnaire (out-patient satisfaction) : Likert type scale with 5 ordered modalities (bad to excellent), rated from 1 to 5.
Time frame: 6 months
Health care teams satisfaction
Satisfaction of health care teams : qualitative questionnaire with 4 ordered modalities (very satisfied to not satisfied)
Time frame: 6 months
Rate of emergency consultations and hospitalizations
Need for unexpected health care
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.